Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Wave Life Sci Ord Sh (WVE)

43.5 1.5 (3.57%)

04-20 16:00

Open:

42

Pre. Close:

42

High:

43.75

Low:

42

Volume:

107,926

Market Cap:

1265M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

43.799 - 43.973

43.973 - 44.123

Low:

41.528 - 41.739

41.739 - 41.92

Close:

43.129 - 43.479

43.479 - 43.781

Technical analysis  (as of: 2018-04-20 4:34:55 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 54.25     One year: 63.37

Support:

Support1: 40.98    Support2: 37.60

Resistance:

Resistance1: 46.45    Resistance2: 54.25

Pivot:

41.80

Moving Averages:

MA(5): 42.17     MA(20): 41.25

MA(100): 40.65     MA(250): 29.16

MACD:

MACD(12,26): -0.11     Signal(12,26,9): -0.43

%K %D:

%K(14,3): 54.80     %D(3): 50.65

RSI:

RSI(14): 54.71

52-Week:

High: 55.95  Low: 15.15  Change(%): 114.8

Average Vol(K):

3-Month: 16423  10-Days 14191

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
WVE has closed below upper band by 16.3%. Bollinger Bands are 48.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to WVE's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-12T09:15:11-04:00
Dosing underway in early-stage study of Pfizer's DMD candidate

2018-04-10T11:10:46-04:00
Wave Life Sciences teams up with Deep Genomics to develop neuromuscular therapies; shares up 2%

2018-04-04T11:14:00-04:00
Oryzon Genomics on go with mid-stage study of Alzheimer's candidate ORY-2001

2018-03-12T08:03:04-04:00
Wave Life Sciences misses by $0.15, beats on revenue

2018-02-21T11:49:59-05:00
Your Daily Pharma Scoop: Portola Update, Wave Life Sciences To Collaborate With Takeda, AbbVie Reports Data For Egolix

2018-02-21T02:42:33-05:00
U.S. Biotech/Pharma Sector Daily Observations Letter: February 20, 2018

2018-02-20T12:47:14-05:00
Midday Gainers / Losers (2/20/2018)

2018-02-20T12:12:39-05:00
Wave Life Sciences teams up with Takeda to develop CNS treatments

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

29.09

Shares Float (M)

28.52

% Held by Insiders

2.00

% Held by Institutions

97.20

Shares Short (K)

2956

Shares Short Prior Month (K)

1910

Stock Financials

EPS

-3.840

EPS Est. Current Year

-3.710

EPS Est. Next Year

-3.680

EPS Est. Next Quarter

Forward EPS

-3.401

Book Value (p.s.)

8.870

PEG Ratio

Profit Margin

Operating Margin

-2769.44

Return on Assets (ttm)

-58.9

Return on Equity (ttm)

-74.3

Qtrly Rev. Growth

147.9

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.432

Qtrly Earnings Growth

Operating Cash Flow (M)

-83.67

Levered Free Cash Flow (M)

-67.48

atoplab.com

Valuation

P/E

-11.33

P/E Growth Ratio

0.04

P/BV

4.90

P/S

9038679040.00

P/CF

-15.12

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.